CN115354024A - Blood sample exosome extraction kit based on combination of protease treatment, SEC (SEC-activated charcoal) column and membrane filtration technology and application - Google Patents
Blood sample exosome extraction kit based on combination of protease treatment, SEC (SEC-activated charcoal) column and membrane filtration technology and application Download PDFInfo
- Publication number
- CN115354024A CN115354024A CN202210914640.8A CN202210914640A CN115354024A CN 115354024 A CN115354024 A CN 115354024A CN 202210914640 A CN202210914640 A CN 202210914640A CN 115354024 A CN115354024 A CN 115354024A
- Authority
- CN
- China
- Prior art keywords
- transfer
- protease
- centrifuge tube
- column
- sec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001808 exosome Anatomy 0.000 title claims abstract description 81
- 108091005804 Peptidases Proteins 0.000 title claims abstract description 42
- 239000004365 Protease Substances 0.000 title claims abstract description 42
- 210000004369 blood Anatomy 0.000 title claims abstract description 42
- 239000008280 blood Substances 0.000 title claims abstract description 42
- 238000000605 extraction Methods 0.000 title claims abstract description 20
- 238000005516 engineering process Methods 0.000 title claims abstract description 11
- 238000005374 membrane filtration Methods 0.000 title claims abstract description 11
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title claims abstract 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title abstract 4
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 41
- 239000000243 solution Substances 0.000 claims description 47
- 238000005119 centrifugation Methods 0.000 claims description 46
- 239000012528 membrane Substances 0.000 claims description 30
- 239000006228 supernatant Substances 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000003480 eluent Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 102000057297 Pepsin A Human genes 0.000 claims description 6
- 108090000284 Pepsin A Proteins 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229940111202 pepsin Drugs 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 108090000631 Trypsin Proteins 0.000 claims description 5
- 102000004142 Trypsin Human genes 0.000 claims description 5
- 230000029087 digestion Effects 0.000 claims description 5
- 239000012154 double-distilled water Substances 0.000 claims description 5
- 229940088598 enzyme Drugs 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 230000013777 protein digestion Effects 0.000 claims description 5
- 239000012588 trypsin Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 abstract description 21
- 102000004169 proteins and genes Human genes 0.000 abstract description 20
- 108090000623 proteins and genes Proteins 0.000 abstract description 20
- 239000012535 impurity Substances 0.000 abstract description 16
- 210000004027 cell Anatomy 0.000 abstract description 8
- 108010088751 Albumins Proteins 0.000 abstract description 6
- 102000009027 Albumins Human genes 0.000 abstract description 6
- 238000000746 purification Methods 0.000 abstract description 6
- 102000007592 Apolipoproteins Human genes 0.000 abstract description 5
- 108010071619 Apolipoproteins Proteins 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 238000001085 differential centrifugation Methods 0.000 abstract description 3
- 229920000642 polymer Polymers 0.000 abstract description 3
- 108010033276 Peptide Fragments Proteins 0.000 abstract 1
- 102000007079 Peptide Fragments Human genes 0.000 abstract 1
- 239000002953 phosphate buffered saline Substances 0.000 description 33
- 102000035195 Peptidases Human genes 0.000 description 32
- 235000019419 proteases Nutrition 0.000 description 32
- 239000011324 bead Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 108010067770 Endopeptidase K Proteins 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 125000000962 organic group Chemical group 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000000464 low-speed centrifugation Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000005199 ultracentrifugation Methods 0.000 description 2
- 102000005666 Apolipoprotein A-I Human genes 0.000 description 1
- 108010059886 Apolipoprotein A-I Proteins 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102100025222 CD63 antigen Human genes 0.000 description 1
- 102100037904 CD9 antigen Human genes 0.000 description 1
- 101710163595 Chaperone protein DnaK Proteins 0.000 description 1
- 101710178376 Heat shock 70 kDa protein Proteins 0.000 description 1
- 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 description 1
- 101000934368 Homo sapiens CD63 antigen Proteins 0.000 description 1
- 101000738354 Homo sapiens CD9 antigen Proteins 0.000 description 1
- 101000613251 Homo sapiens Tumor susceptibility gene 101 protein Proteins 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 102100040879 Tumor susceptibility gene 101 protein Human genes 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000035992 intercellular communication Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 210000002487 multivesicular body Anatomy 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C12N2509/10—Mechanical dissociation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
技术领域technical field
本发明是一种提取试剂盒,特别涉及一种基于蛋白酶处理、SEC柱和膜滤技术相结合的血液样本外泌体提取试剂盒及应用。The invention is an extraction kit, in particular to a blood sample exosome extraction kit and its application based on the combination of protease treatment, SEC column and membrane filtration technology.
背景技术Background technique
目前,血液样品中提取外泌体的最常见的方法有超速离心法、PEG沉淀试剂法、SEC柱法、超滤法和免疫磁珠法等。超速离心法和免疫磁珠法受到仪器和耗材的限制,且成本高。其他几种方法的提取试剂盒在血液样品中提取的效果并不佳,是由于血液样本自身的特殊性。血液样本除去细胞和血小板后,仍然存在很多的杂质血液蛋白质,如白蛋白和载脂蛋白,蛋白聚合体等。这些血液中的杂质蛋白有些和外泌体的分子尺寸非常相近,对提取纯化外泌体造成了很大的困难,通过简单的sec柱法或者超滤法都很难得到高质量的外泌体。外泌体常见的三种检测手段western blot、NTA和电镜检测。特别是血液样品中的电镜检测效果容易受杂质影响,很难找到清晰的外泌体形态图。At present, the most common methods for extracting exosomes from blood samples include ultracentrifugation, PEG precipitation reagent method, SEC column method, ultrafiltration method, and immunomagnetic bead method. Ultracentrifugation and immunomagnetic bead methods are limited by instruments and consumables, and are costly. The extraction kits of several other methods do not perform well in the extraction of blood samples, which is due to the particularity of the blood samples themselves. After removing the cells and platelets from the blood sample, there are still a lot of impurity blood proteins, such as albumin and apolipoprotein, protein aggregates and so on. Some of these impurity proteins in the blood are very similar to the molecular size of exosomes, which has caused great difficulties in the extraction and purification of exosomes. It is difficult to obtain high-quality exosomes by simple sec column method or ultrafiltration method. . Three common detection methods for exosomes are western blot, NTA and electron microscopy. In particular, the electron microscope detection effect in blood samples is easily affected by impurities, and it is difficult to find a clear exosome morphology map.
外泌体是由多泡体与细胞膜融合后,释放到细胞外的,直径介于30-150nm的膜性小囊泡,具有磷脂双分子层结构的囊泡,广泛存在于各种体液中,其内含有蛋白质、脂质、核酸等多种活性生物分子。外泌体是细胞间通讯的载体。专利“血清或血浆中的外泌体制备试剂盒及外泌体制备方法”中应用到PEG沉淀、蛋白酶K预处理以及纯化微球的使用。PEG沉淀法的原理为:通过聚合物劫持水分子,使得外泌体溶解度降低,进而在低速离心条件下发生沉降。蛋白酶K预处理:用蛋白酶K(一种具有广泛特异性的丝氨酸蛋白酶)预处理血清或血浆样品,对于在纯化过程中减少白蛋白和与外泌体相关的载脂蛋白A-1和B的数量至关重要。琼脂糖珠与有机基团进行了偶联,偶联了有机基团的琼脂糖珠可以吸附沉降下来的杂质蛋白颗粒,使得提取得到的外泌体纯度更高。此方法缺点是PEG会和外泌体共同沉降下来,产生难以去除的聚合物,琼脂糖珠偶联有机基团,操作复杂成本高。专利“一种提取血浆外泌体的试剂盒及其应用”中采用了亲和素修饰的纳米磁珠溶液、生物素修饰的特异性适配体溶液和磁分离装置。缺点试剂成本高。专利“人血浆外泌体的快速、高纯分离方法”首先利用琼脂糖凝胶小柱对人血浆进行预分离,除去大部分尺寸较小的高丰度蛋白;并将收集得到的馏分依次进行合并,超滤浓缩;然后利用高效液相体积排阻色谱分离,实现外泌体和干扰脂蛋白的分离,最终得到高纯的人血浆外泌体馏分。需要用到高效液相色谱,设备成本高。专利“一种高效快速分离血浆外泌体的方法”包括以下步骤:步骤一:配制得亲水聚合物溶液;步骤二:稀释得稀释后的血浆;步骤三:离心去除血浆中的细胞成分得去除细胞的血浆;步骤四:进行超高速离心沉淀得沉淀外泌体;步骤五:使用磷酸缓冲盐溶液悬浮得悬浮的外泌体;步骤六:使用酚和硫氰酸胍的单相溶液得重新溶解的悬浮外泌体;步骤七:加入200μl氯仿并振荡15秒后得振荡后的外泌体溶液;步骤八:离心15分钟得分层的外泌体溶液;步骤九:吸取最上层的无色液体得上清层液体;步骤十:加入同等体积的异丙醇进行沉淀得高纯度的外泌体沉淀物。此方法用到有机试剂毒性大,可能污染破坏外泌体。Exosomes are small membranous vesicles with a diameter of 30-150nm that are released outside the cell after the fusion of multivesicular bodies and cell membranes. They are vesicles with a phospholipid bilayer structure and are widely present in various body fluids. It contains a variety of active biomolecules such as proteins, lipids, and nucleic acids. Exosomes are vehicles for intercellular communication. The patent "Exosome Preparation Kit and Exosome Preparation Method in Serum or Plasma" is applied to PEG precipitation, proteinase K pretreatment and the use of purified microspheres. The principle of the PEG precipitation method is: the polymer hijacks water molecules to reduce the solubility of exosomes, and then settles under low-speed centrifugation conditions. Proteinase K pretreatment: Pretreatment of serum or plasma samples with proteinase K, a serine protease with broad specificity, is useful for reducing albumin and exosome-associated apolipoproteins A-1 and B during purification. Quantity matters. The agarose beads are coupled with organic groups, and the agarose beads coupled with organic groups can adsorb the impurity protein particles that have settled down, making the extracted exosomes more pure. The disadvantage of this method is that PEG will co-sediment with exosomes, resulting in polymers that are difficult to remove, and the agarose beads are coupled with organic groups, which makes the operation complicated and costly. The patent "a kit for extracting plasma exosomes and its application" uses avidin-modified nano magnetic bead solution, biotin-modified specific aptamer solution and magnetic separation device. Disadvantage: High cost of reagents. The patent "rapid and high-purity separation method for human plasma exosomes" firstly uses agarose gel column to pre-separate human plasma to remove most of the small-sized high-abundance proteins; and the collected fractions are sequentially processed Combined, concentrated by ultrafiltration; and then separated by high-performance liquid phase size exclusion chromatography to achieve the separation of exosomes and interfering lipoproteins, and finally obtain high-purity human plasma exosome fractions. High-performance liquid chromatography is required, and the equipment cost is high. The patent "A Method for Efficiently and Quickly Separating Exosomes from Plasma" includes the following steps: Step 1: Prepare a hydrophilic polymer solution; Step 2: Dilute to obtain diluted plasma; Step 3: Centrifuge to remove cellular components in the plasma to obtain Cell-removed plasma; Step 4: Precipitate exosomes by ultra-high-speed centrifugation; Step 5: Suspend exosomes using phosphate buffered saline; Step 6: Use a single-phase solution of phenol and guanidine thiocyanate to obtain Re-dissolved suspended exosomes; Step 7: Add 200 μl chloroform and shake for 15 seconds to obtain the shaken exosome solution; Step 8: Centrifuge the layered exosome solution for 15 minutes; Step 9: Draw the top layer The supernatant liquid was obtained from the colorless liquid; Step 10: Add an equal volume of isopropanol for precipitation to obtain a high-purity exosome precipitate. This method uses organic reagents that are highly toxic and may contaminate and destroy exosomes.
上述所提及的专利:Patents mentioned above:
专利“血清或血浆中的外泌体制备试剂盒及外泌体制备方法”CN 108918228 APatent "Exosome Preparation Kit and Exosome Preparation Method in Serum or Plasma" CN 108918228 A
专利“一种提取血浆外泌体的试剂盒及其应用”CN 109266606 APatent "a kit for extracting plasma exosomes and its application" CN 109266606 A
专利“人血浆外泌体的快速、高纯分离方法”CN 113252808 APatent "Rapid and high-purity separation method of human plasma exosomes" CN 113252808 A
专利“一种高效快速分离血浆外泌体的方法”CN 111996165 APatent "A method for efficiently and rapidly separating plasma exosomes" CN 111996165 A
发明内容Contents of the invention
一种基于蛋白酶处理、SEC柱和膜滤技术相结合的血液样本外泌体提取试剂盒及应用。该方法通过三步差速离心,除去细胞、血小板和非外泌体微泡。又通过针孔式过滤器去除220nm以上杂质,再通过蛋白酶处理溶解杂质蛋白(白蛋白和载脂蛋白等)或使蛋白聚合体分解成小的肽段,然后通过超滤法去除10nm以下的杂质。留下的样本分子尺寸处于外泌体的分子尺寸范围,最后通过SEC柱在外泌体区域得到纯化外泌体,最后根据浓度要求,再进一步超滤,纯化并浓缩得到高质量外泌体。该组合方法简单易行,效果显著,成功解决了血液样品成分复杂,杂蛋白多,外泌体分离提取难度大,电镜下难于找到清晰的外泌体囊泡状结构等问题。A blood sample exosome extraction kit and application based on the combination of protease treatment, SEC column and membrane filtration technology. The method uses three steps of differential centrifugation to remove cells, platelets, and non-exosomal microvesicles. Remove impurities above 220nm through a pinhole filter, then dissolve impurity proteins (albumin and apolipoprotein, etc.) by protease treatment or decompose protein aggregates into small peptides, and then remove impurities below 10nm by ultrafiltration . The molecular size of the remaining sample is within the molecular size range of exosomes. Finally, the exosomes are purified in the exosome area through the SEC column. Finally, according to the concentration requirements, further ultrafiltration, purification and concentration are performed to obtain high-quality exosomes. The combination method is simple and easy to implement, and the effect is remarkable. It successfully solves the problems of complex components of blood samples, many impurities, difficult separation and extraction of exosomes, and difficulty in finding clear vesicle-like structures of exosomes under the electron microscope.
本发明的上述技术问题主要是通过下述技术方案得以解决的:Above-mentioned technical problem of the present invention is mainly solved by following technical scheme:
一种基于蛋白酶处理、SEC柱和膜滤技术相结合的血液样本外泌体提取试剂盒及应用,按以下步骤进行:A blood sample exosome extraction kit and application based on the combination of protease treatment, SEC column and membrane filtration technology, according to the following steps:
(1)、收集管收集到人血液:温度为4℃,重量为200~500g,离心时间为5-10min,离心结束后转移上清到新的离心管;(1) Human blood is collected in the collection tube: the temperature is 4°C, the weight is 200-500g, the centrifugation time is 5-10min, and the supernatant is transferred to a new centrifuge tube after centrifugation;
(2)、转移后的上清:温度为4℃,重量为2000~2500g,离心时间为10~15min,离心结束后陆续转移上清到新的离心管;(2) Supernatant after transfer: the temperature is 4°C, the weight is 2000-2500g, and the centrifugation time is 10-15min. After the centrifugation, transfer the supernatant to a new centrifuge tube;
步骤(1)与(2)分二个步骤,其原因在于:第一次低速离心是为了把血液中完整的细胞等离心下来,第二次离心提高转速是为了离心一些已经破碎的细胞内容物或者杂质等。如果第一次就转速高,很可能细胞会破裂,内容物释放,无法完全沉淀下来,造成后期外泌体纯化污染。Steps (1) and (2) are divided into two steps. The reason is that the first low-speed centrifugation is to centrifuge the complete cells in the blood, and the second centrifugation increases the speed to centrifuge some broken cell contents. Or impurities, etc. If the rotation speed is high for the first time, it is likely that the cells will rupture, and the contents will be released, which cannot be completely precipitated, resulting in contamination of exosome purification in the later stage.
(3)、等步骤(2)结束后,转移上清到新的离心管,作为人血浆样品;(3) After step (2) is finished, transfer the supernatant to a new centrifuge tube as a human plasma sample;
(4)、用PBS将步骤(3)制得的血浆进行稀释,稀释血浆至2倍体积,再进行离心操作:温度为4℃,重量为10000-18000g,离心时间为30min,离心结束后转移上清到新的离心管;(4) Dilute the plasma prepared in step (3) with PBS, dilute the plasma to 2 times the volume, and then perform centrifugation: the temperature is 4°C, the weight is 10000-18000g, the centrifugation time is 30min, and the centrifugation is completed. Transfer Transfer the supernatant to a new centrifuge tube;
(5)、步骤(4)后,将新的离心管的血液依次通过0.8um滤膜和0.22um滤膜进行过滤处理;(5), after step (4), filter the blood of the new centrifuge tube through 0.8um filter membrane and 0.22um filter membrane successively;
(6)、对步骤(5)中过滤后的血液进行蛋白酶消化处理,蛋白酶为胃蛋白酶、胰蛋白酶或其它具有蛋白消化功能的酶中的一种或多种;(6), carry out protease digestion treatment to the blood filtered in step (5), protease is one or more in pepsin, trypsin or other enzymes with protein digestion function;
配制蛋白酶溶液50-1000ug/ml,血液样本加入蛋白酶溶液50-1000ul/ml,旋涡30秒混匀:蛋白酶用PBS或双蒸水稀释。Prepare protease solution 50-1000ug/ml, add protease solution 50-1000ul/ml to blood sample, vortex for 30 seconds and mix well: dilute protease with PBS or double distilled water.
(7)、步骤(6)后,将混匀后的溶液加入到温度为37℃的水浴锅中孵育5~60分钟;(7), after step (6), add the mixed solution into a water bath with a temperature of 37° C. and incubate for 5 to 60 minutes;
(8)、步骤(7)后,转移到60℃水浴锅中孵育3~15分钟;(8), after step (7), transfer to a 60°C water bath and incubate for 3 to 15 minutes;
(9)、步骤(8)后,转移样品到预处理过的100KD超滤管中,温度为4℃,重量为3000-4500g,离心时间为5-15min;弃滤过液,超滤管内液体转移到新的离心管中,用移液枪取适量PBS轻轻吹洗超滤管的滤膜数次,并转移溶液到方才的离心管中,离心管中样品量终体积为0.5-3ml;(9), after step (8), transfer the sample to the pretreated 100KD ultrafiltration tube, the temperature is 4°C, the weight is 3000-4500g, and the centrifugation time is 5-15min; discard the filtrate, and the liquid in the ultrafiltration tube Transfer to a new centrifuge tube, use a pipette gun to take an appropriate amount of PBS to gently flush the filter membrane of the ultrafiltration tube several times, and transfer the solution to the previous centrifuge tube, the final volume of the sample in the centrifuge tube is 0.5-3ml;
(10)柱平衡:3倍柱体积的PBS溶液润洗SEC柱;润洗完成,待底盖出口无液体流出后,加入步骤(9)离心管中样品,待底盖出口样品流尽,无液体流出,再加洗脱液PBS溶液,空柱体积为前1.5ml不收集,收集所需外泌体的体积为空柱体积之后的1~4ml洗脱液;(10) Column balance: Rinse the SEC column with PBS solution of 3 times the column volume; after the rinsing is completed, after no liquid flows out from the outlet of the bottom cover, add the sample in the centrifuge tube in step (9), and wait until the sample at the outlet of the bottom cover has flowed out. After the liquid flows out, add the eluent PBS solution. The empty column volume is the first 1.5ml without collection, and the volume of exosomes required for collection is 1-4ml eluent after the empty column volume;
(11)、转移收集的洗脱液到100KD超滤管,温度为4℃,重量为3000-4500g,离心时间为5-15min;弃滤过液,根据外泌体浓度需求,加0.2~1ml的PBS溶液于100KDa超滤管的滤膜上,静置1~3min;用移液枪吸取滤膜上的PBS溶液,轻轻吹洗超滤膜数次,收取所需浓度的外泌体,于﹣80摄氏度保存。(11) Transfer the collected eluate to a 100KD ultrafiltration tube at a temperature of 4°C, a weight of 3000-4500g, and a centrifugation time of 5-15min; discard the filtrate, and add 0.2-1ml according to the concentration of exosomes Put the PBS solution on the filter membrane of a 100KDa ultrafiltration tube, and let it stand for 1-3 minutes; use a pipette gun to absorb the PBS solution on the filter membrane, gently blow and wash the ultrafiltration membrane several times, and collect the exosomes with the required concentration. Store at -80°C.
作为优选,步骤(10)中,3倍柱体积为20ml;PBS溶液的pH为7.2~7.4。As a preference, in step (10), the 3 times column volume is 20ml; the pH of the PBS solution is 7.2-7.4.
本发明公开了一种基于蛋白酶处理、SEC柱和膜滤技术相结合的血液样本外泌体提取试剂盒及应用。通过三步差速离心,除去细胞、血小板和非外泌体微泡。又通过针孔式过滤器去除220nm以上杂质,再通过蛋白酶处理溶解杂质蛋白(白蛋白和载脂蛋白等)或使蛋白聚合体分解成小的肽段,然后通过超滤法去除10nm以下的杂质。留下的样本分子尺寸处于外泌体的分子尺寸范围,最后通过SEC柱在外泌体区域得到纯化外泌体,最后根据浓度要求,再进一步超滤,纯化并浓缩得到高质量外泌体。该组合方法简单易行,效果显著。特别是后续操作前的蛋白酶使用,不仅溶解了部分杂蛋白,还使得蛋白聚合体分解成小的肽段,杂蛋白再通过超滤和SEC柱逐一去除。由于血液样品成分复杂,杂蛋白多,有些蛋白以及蛋白聚合体和外泌体尺寸大小类似,简单通过SEC柱或超滤根本无法成功的与外泌体分离。此组合方法,解决了血液样品成分复杂,杂蛋白多,外泌体分离提取难度大,电镜下难于找到清晰的外泌体囊泡状结构等问题。The invention discloses a blood sample exosome extraction kit and its application based on the combination of protease treatment, SEC column and membrane filtration technology. Cells, platelets, and non-exosomal microvesicles are removed by three-step differential centrifugation. Remove impurities above 220nm through a pinhole filter, then dissolve impurity proteins (albumin and apolipoprotein, etc.) by protease treatment or decompose protein aggregates into small peptides, and then remove impurities below 10nm by ultrafiltration . The molecular size of the remaining sample is within the molecular size range of exosomes. Finally, the exosomes are purified in the exosome area through the SEC column. Finally, according to the concentration requirements, further ultrafiltration, purification and concentration are performed to obtain high-quality exosomes. The combination method is simple and easy to implement, and the effect is remarkable. In particular, the use of protease before subsequent operations not only dissolves part of the miscellaneous proteins, but also decomposes the protein aggregates into small peptides, and the miscellaneous proteins are then removed one by one by ultrafiltration and SEC columns. Due to the complex composition of blood samples and many miscellaneous proteins, some proteins and protein aggregates are similar in size to exosomes, and they cannot be successfully separated from exosomes simply by SEC column or ultrafiltration. This combination method solves the problems of complex components of blood samples, many impurities, difficult separation and extraction of exosomes, and difficulty in finding clear vesicle-like structures of exosomes under the electron microscope.
附图说明Description of drawings
图1为本发明中western blot方法验证血浆外泌体提取结果;Fig. 1 is the western blot method verification plasma exosome extraction result in the present invention;
图1中HSP70,TSG101,CD9和CD63为人类的外泌体标志性蛋白;In Figure 1, HSP70, TSG101, CD9 and CD63 are human exosome marker proteins;
图2为本发明中血浆外泌体提取NTA结果;Fig. 2 is the result of extracting NTA from plasma exosomes in the present invention;
图2中稀释1000倍上机,ZetaView纳米颗粒跟踪分析仪进行NTA检测;上机检测浓度为7.7×107particles/ml,原外泌体浓度7.7×1010particles/ml。In Figure 2, it was diluted 1000 times on the computer, and the ZetaView nanoparticle tracking analyzer was used for NTA detection; the detection concentration on the computer was 7.7×10 7 particles/ml, and the original exosome concentration was 7.7×10 10 particles/ml.
图3为本发明中血浆外泌体提取电镜结果;Fig. 3 is the plasma exosome extraction electron microscope result in the present invention;
图4为本发明中western blot方法验证胃蛋白酶处理血浆样品;Fig. 4 is that the western blot method in the present invention verifies the pepsin treatment plasma sample;
图4中Albumin和Apolipoprotein A1去除效果。1:蛋白酶处理前2:蛋白酶处理后。Albumin and Apolipoprotein A1 removal effect in Figure 4. 1: before protease treatment 2: after protease treatment.
图5为本发明中SEC柱去除杂蛋白外泌体收集图。Fig. 5 is a collection diagram of the SEC column in the present invention to remove foreign protein exosomes.
具体实施方式Detailed ways
下面通过实施例,并结合附图,对本发明的技术方案作进一步具体的说明。The technical solutions of the present invention will be further specifically described below through the embodiments and in conjunction with the accompanying drawings.
实施例1:一种基于蛋白酶处理、SEC柱和膜滤技术相结合的血液样本外泌体提取试剂盒及应用,按以下步骤进行:Example 1: A blood sample exosome extraction kit and application based on the combination of protease treatment, SEC column and membrane filtration technology, according to the following steps:
(1)、收集管收集到人血液:温度为4℃,重量为200g,离心时间为5min,离心结束后转移上清到新的离心管;(1) Human blood is collected in the collection tube: the temperature is 4°C, the weight is 200g, the centrifugation time is 5min, and the supernatant is transferred to a new centrifuge tube after centrifugation;
(2)、转移后的上清:温度为4℃,重量为2000g,离心时间为10min,离心结束后陆续转移上清到新的离心管;(2) Supernatant after transfer: the temperature is 4°C, the weight is 2000g, and the centrifugation time is 10min. After the centrifugation, the supernatant is successively transferred to a new centrifuge tube;
(3)、等步骤(2)结束后,转移上清到新的离心管,作为人血浆样品;(3) After step (2) is finished, transfer the supernatant to a new centrifuge tube as a human plasma sample;
(4)、用PBS将步骤(3)制得的血浆进行稀释,稀释血浆至2倍体积,再进行离心操作:温度为4℃,重量为10000-18000g,离心时间为30min,离心结束后转移上清到新的离心管;(4) Dilute the plasma prepared in step (3) with PBS, dilute the plasma to 2 times the volume, and then perform centrifugation: the temperature is 4°C, the weight is 10000-18000g, the centrifugation time is 30min, and the centrifugation is completed. Transfer Transfer the supernatant to a new centrifuge tube;
(5)、步骤(4)后,将新的离心管的血液依次通过0.8um滤膜和0.22um滤膜进行过滤处理;(5), after step (4), filter the blood of the new centrifuge tube through 0.8um filter membrane and 0.22um filter membrane successively;
(6)、对步骤(5)中过滤后的血液进行蛋白酶消化处理,蛋白酶为胃蛋白酶、胰蛋白酶或其它具有蛋白消化功能的酶中的一种或多种;(6), carry out protease digestion treatment to the blood filtered in step (5), protease is one or more in pepsin, trypsin or other enzymes with protein digestion function;
配制蛋白酶溶液50-1000ug/ml,血液样本加入蛋白酶溶液50-1000ul/ml,旋涡30秒混匀:蛋白酶用PBS或双蒸水稀释。Prepare protease solution 50-1000ug/ml, add protease solution 50-1000ul/ml to blood sample, vortex for 30 seconds and mix well: dilute protease with PBS or double distilled water.
(7)、步骤(6)后,将混匀后的溶液加入到温度为37℃的水浴锅中孵育5分钟;(7), after step (6), add the mixed solution into a water bath with a temperature of 37°C and incubate for 5 minutes;
(8)、步骤(7)后,转移到60℃水浴锅中孵育3分钟;(8), after step (7), transfer to a 60°C water bath and incubate for 3 minutes;
(9)、步骤(8)后,转移样品到预处理过的100KD超滤管中,温度为4℃,重量为3000-4500g,离心时间为5min;弃滤过液,超滤管内液体转移到新的离心管中,用移液枪取适量PBS轻轻吹洗超滤管的滤膜数次,并转移溶液到方才的离心管中,离心管中样品量终体积为0.5ml;(9), after step (8), transfer the sample to the pretreated 100KD ultrafiltration tube, the temperature is 4°C, the weight is 3000-4500g, and the centrifugation time is 5min; the filtrate is discarded, and the liquid in the ultrafiltration tube is transferred to In a new centrifuge tube, use a pipette gun to take an appropriate amount of PBS to gently rinse the filter membrane of the ultrafiltration tube several times, and transfer the solution to the previous centrifuge tube. The final volume of the sample in the centrifuge tube is 0.5ml;
(10)柱平衡:3倍柱体积的PBS溶液润洗SEC柱;润洗完成,待底盖出口无液体流出后,加入步骤(9)离心管中样品,待底盖出口样品流尽,无液体流出,再加洗脱液PBS溶液,空柱体积为前1.5ml不收集,收集所需外泌体的体积为空柱体积之后的1ml洗脱液;(10) Column balance: Rinse the SEC column with PBS solution of 3 times the column volume; after the rinsing is completed, after no liquid flows out from the outlet of the bottom cover, add the sample in the centrifuge tube in step (9), and wait until the sample at the outlet of the bottom cover has flowed out. After the liquid flows out, add the eluent PBS solution. The volume of the empty column is the first 1.5ml without collection, and the volume of exosomes required for collection is 1ml of the eluent after the volume of the empty column;
(11)、转移收集的洗脱液到100KD超滤管,温度为4℃,重量为3000-4500g,离心时间为5-15min;弃滤过液,根据外泌体浓度需求,加0.2ml的PBS溶液于100KDa超滤管的滤膜上,静置1min;用移液枪吸取滤膜上的PBS溶液,轻轻吹洗超滤膜数次,收取所需浓度的外泌体,于﹣80摄氏度保存。(11) Transfer the collected eluate to a 100KD ultrafiltration tube at a temperature of 4°C, a weight of 3000-4500g, and a centrifugation time of 5-15min; discard the filtrate, and add 0.2ml of Put the PBS solution on the filter membrane of a 100KDa ultrafiltration tube and let it stand for 1min; use a pipette gun to absorb the PBS solution on the filter membrane, gently blow and wash the ultrafiltration membrane several times, collect the exosomes with the required concentration, and store them at -80 Store in Celsius.
步骤(10)中,3倍柱体积为20ml;PBS溶液的pH为7.2。In step (10), 3 times the column volume is 20ml; the pH of the PBS solution is 7.2.
实施例2:一种基于蛋白酶处理、SEC柱和膜滤技术相结合的血液样本外泌体提取试剂盒及应用,按以下步骤进行:Example 2: A blood sample exosome extraction kit based on protease treatment, SEC column and membrane filtration technology and its application, according to the following steps:
(1)、收集管收集到人血液:温度为4℃,重量为300g,离心时间为7min,离心结束后转移上清到新的离心管;(1) Human blood is collected in the collection tube: the temperature is 4°C, the weight is 300g, the centrifugation time is 7min, and the supernatant is transferred to a new centrifuge tube after centrifugation;
(2)、转移后的上清:温度为4℃,重量为2200g,离心时间为12min,离心结束后陆续转移上清到新的离心管;(2) Supernatant after transfer: the temperature is 4°C, the weight is 2200g, the centrifugation time is 12min, and the supernatant is successively transferred to a new centrifuge tube after centrifugation;
(3)、等步骤(2)结束后,转移上清到新的离心管,作为人血浆样品;(3) After step (2) is finished, transfer the supernatant to a new centrifuge tube as a human plasma sample;
(4)、用PBS将步骤(3)制得的血浆进行稀释,稀释血浆至2倍体积,再进行离心操作:温度为4℃,重量为15000g,离心时间为30min,离心结束后转移上清到新的离心管;(4) Dilute the plasma prepared in step (3) with PBS, dilute the plasma to 2 times the volume, and then perform centrifugation: the temperature is 4°C, the weight is 15000g, the centrifugation time is 30min, and the supernatant is transferred after centrifugation to a new centrifuge tube;
(5)、步骤(4)后,将新的离心管的血液依次通过0.8um滤膜和0.22um滤膜进行过滤处理;(5), after step (4), filter the blood of the new centrifuge tube through 0.8um filter membrane and 0.22um filter membrane successively;
(6)、对步骤(5)中过滤后的血液进行蛋白酶消化处理,蛋白酶为胃蛋白酶、胰蛋白酶或其它具有蛋白消化功能的酶中的一种或多种;(6), carry out protease digestion treatment to the blood filtered in step (5), protease is one or more in pepsin, trypsin or other enzymes with protein digestion function;
配制蛋白酶溶液800ug/ml,血液样本加入蛋白酶溶液800ul/ml,旋涡30秒混匀:蛋白酶用PBS或双蒸水稀释。Prepare 800ug/ml protease solution, add 800ul/ml protease solution to the blood sample, vortex for 30 seconds and mix well: dilute protease with PBS or double distilled water.
(7)、步骤(6)后,将混匀后的溶液加入到温度为37℃的水浴锅中孵育25分钟;(7), after step (6), add the mixed solution into a water bath with a temperature of 37°C and incubate for 25 minutes;
(8)、步骤(7)后,转移到60℃水浴锅中孵育8分钟;(8), after step (7), transfer to a 60°C water bath and incubate for 8 minutes;
(9)、步骤(8)后,转移样品到预处理过的100KD超滤管中,温度为4℃,重量为3500g,离心时间为10min;弃滤过液,超滤管内液体转移到新的离心管中,用移液枪取适量PBS轻轻吹洗超滤管的滤膜数次,并转移溶液到方才的离心管中,离心管中样品量终体积为2ml;(9), after step (8), transfer the sample to the pretreated 100KD ultrafiltration tube, the temperature is 4°C, the weight is 3500g, and the centrifugation time is 10min; the filtrate is discarded, and the liquid in the ultrafiltration tube is transferred to a new In the centrifuge tube, use a pipette gun to take an appropriate amount of PBS to gently flush the filter membrane of the ultrafiltration tube several times, and transfer the solution to the centrifuge tube just now. The final volume of the sample in the centrifuge tube is 2ml;
(10)柱平衡:3倍柱体积的PBS溶液润洗SEC柱;润洗完成,待底盖出口无液体流出后,加入步骤(9)离心管中样品,待底盖出口样品流尽,无液体流出,再加洗脱液PBS溶液,空柱体积为前1.5ml不收集,收集所需外泌体的体积为空柱体积之后的2ml洗脱液;(10) Column balance: Rinse the SEC column with PBS solution of 3 times the column volume; after the rinsing is completed, after no liquid flows out from the outlet of the bottom cover, add the sample in the centrifuge tube in step (9), and wait until the sample at the outlet of the bottom cover has flowed out. The liquid flows out, then add the eluent PBS solution, the volume of the empty column is the first 1.5ml without collecting, and the volume of exosomes required for collection is the 2ml eluent after the empty column volume;
(11)、转移收集的洗脱液到100KD超滤管,温度为4℃,重量为3500g,离心时间为10min;弃滤过液,根据外泌体浓度需求,加0.8ml的PBS溶液于100KDa超滤管的滤膜上,静置2min;用移液枪吸取滤膜上的PBS溶液,轻轻吹洗超滤膜数次,收取所需浓度的外泌体,于﹣80摄氏度保存。(11) Transfer the collected eluate to a 100KD ultrafiltration tube at a temperature of 4°C, a weight of 3500g, and a centrifugation time of 10 minutes; discard the filtrate, and add 0.8ml of PBS solution to 100KDa according to the concentration of exosomes On the filter membrane of the ultrafiltration tube, let it stand for 2 minutes; use a pipette gun to absorb the PBS solution on the filter membrane, gently blow and wash the ultrafiltration membrane several times, collect the exosomes of the required concentration, and store them at -80 degrees Celsius.
步骤(10)中,3倍柱体积为20ml;PBS溶液的pH为7.3。In step (10), 3 times the column volume is 20ml; the pH of the PBS solution is 7.3.
实施例3:一种基于蛋白酶处理、SEC柱和膜滤技术相结合的血液样本外泌体提取试剂盒及应用,按以下步骤进行:Example 3: A blood sample exosome extraction kit based on protease treatment, SEC column and membrane filtration technology and its application, according to the following steps:
(1)、收集管收集到人血液:温度为4℃,重量为500g,离心时间为10min,离心结束后转移上清到新的离心管;(1) Human blood is collected in the collection tube: the temperature is 4°C, the weight is 500g, the centrifugation time is 10min, and the supernatant is transferred to a new centrifuge tube after centrifugation;
(2)、转移后的上清:温度为4℃,重量为2500g,离心时间为15min,离心结束后陆续转移上清到新的离心管;(2) Supernatant after transfer: the temperature is 4°C, the weight is 2500g, and the centrifugation time is 15min. After the centrifugation, the supernatant is successively transferred to a new centrifuge tube;
(3)、等步骤(2)结束后,转移上清到新的离心管,作为人血浆样品;(3) After step (2) is finished, transfer the supernatant to a new centrifuge tube as a human plasma sample;
(4)、用PBS将步骤(3)制得的血浆进行稀释,稀释血浆至2倍体积,再进行离心操作:温度为4℃,重量为18000g,离心时间为30min,离心结束后转移上清到新的离心管;(4) Dilute the plasma prepared in step (3) with PBS, dilute the plasma to 2 times the volume, and then perform centrifugation: the temperature is 4°C, the weight is 18000g, the centrifugation time is 30min, and the supernatant is transferred after centrifugation to a new centrifuge tube;
(5)、步骤(4)后,将新的离心管的血液依次通过0.8um滤膜和0.22um滤膜进行过滤处理;(5), after step (4), filter the blood of the new centrifuge tube through 0.8um filter membrane and 0.22um filter membrane successively;
(6)、对步骤(5)中过滤后的血液进行蛋白酶消化处理,蛋白酶为胃蛋白酶、胰蛋白酶或其它具有蛋白消化功能的酶中的一种或多种;(6), carry out protease digestion treatment to the blood filtered in step (5), protease is one or more in pepsin, trypsin or other enzymes with protein digestion function;
配制蛋白酶溶液1000ug/ml,血液样本加入蛋白酶溶液1000ul/ml,旋涡30秒混匀:蛋白酶用PBS或双蒸水稀释。Prepare protease solution 1000ug/ml, add protease solution 1000ul/ml to the blood sample, vortex for 30 seconds and mix well: dilute protease with PBS or double distilled water.
(7)、步骤(6)后,将混匀后的溶液加入到温度为37℃的水浴锅中孵育60分钟;(7), after step (6), add the mixed solution into a water bath with a temperature of 37°C and incubate for 60 minutes;
(8)、步骤(7)后,转移到60℃水浴锅中孵育15分钟;(8), after step (7), transfer to a 60°C water bath and incubate for 15 minutes;
(9)、步骤(8)后,转移样品到预处理过的100KD超滤管中,温度为4℃,重量为4500g,离心时间为15min;弃滤过液,超滤管内液体转移到新的离心管中,用移液枪取适量PBS轻轻吹洗超滤管的滤膜数次,并转移溶液到方才的离心管中,离心管中样品量终体积为3ml;(9), after step (8), transfer the sample to the pretreated 100KD ultrafiltration tube, the temperature is 4°C, the weight is 4500g, and the centrifugation time is 15min; the filtrate is discarded, and the liquid in the ultrafiltration tube is transferred to a new In the centrifuge tube, use a pipette gun to take an appropriate amount of PBS to gently wash the filter membrane of the ultrafiltration tube several times, and transfer the solution to the centrifuge tube just now. The final volume of the sample in the centrifuge tube is 3ml;
(10)柱平衡:3倍柱体积的PBS溶液润洗SEC柱;润洗完成,待底盖出口无液体流出后,加入步骤(9)离心管中样品,待底盖出口样品流尽,无液体流出,再加洗脱液PBS溶液,空柱体积为前1.5ml不收集,收集所需外泌体的体积为空柱体积之后的4ml洗脱液;(10) Column balance: Rinse the SEC column with PBS solution of 3 times the column volume; after the rinsing is completed, after no liquid flows out from the outlet of the bottom cover, add the sample in the centrifuge tube in step (9), and wait until the sample at the outlet of the bottom cover has flowed out. After the liquid flows out, add the eluent PBS solution, the volume of the empty column is the first 1.5ml without collecting, and the volume of exosomes required for collection is the 4ml eluent after the volume of the empty column;
(11)、转移收集的洗脱液到100KD超滤管,温度为4℃,重量为4500g,离心时间为15min;弃滤过液,根据外泌体浓度需求,加1ml的PBS溶液于100KDa超滤管的滤膜上,静置3min;用移液枪吸取滤膜上的PBS溶液,轻轻吹洗超滤膜数次,收取所需浓度的外泌体,于﹣80摄氏度保存。(11) Transfer the collected eluate to a 100KD ultrafiltration tube at a temperature of 4°C, a weight of 4500g, and a centrifugation time of 15 minutes; discard the filtrate, and add 1ml of PBS solution to a 100KDa ultrafiltration tube according to the concentration of exosomes. On the filter membrane of the filter tube, let it stand for 3 minutes; use a pipette gun to absorb the PBS solution on the filter membrane, gently blow and wash the ultrafiltration membrane several times, collect the exosomes with the required concentration, and store them at -80 degrees Celsius.
步骤(10)中,3倍柱体积为20ml;PBS溶液的pH为7.4。In step (10), 3 times the column volume is 20ml; the pH of the PBS solution is 7.4.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210914640.8A CN115354024A (en) | 2022-07-29 | 2022-07-29 | Blood sample exosome extraction kit based on combination of protease treatment, SEC (SEC-activated charcoal) column and membrane filtration technology and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210914640.8A CN115354024A (en) | 2022-07-29 | 2022-07-29 | Blood sample exosome extraction kit based on combination of protease treatment, SEC (SEC-activated charcoal) column and membrane filtration technology and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115354024A true CN115354024A (en) | 2022-11-18 |
Family
ID=84031289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210914640.8A Pending CN115354024A (en) | 2022-07-29 | 2022-07-29 | Blood sample exosome extraction kit based on combination of protease treatment, SEC (SEC-activated charcoal) column and membrane filtration technology and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115354024A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2608509C1 (en) * | 2016-02-11 | 2017-01-18 | Елена Сергеевна Кастарнова | Method of obtaining blood exosomes |
| CN109536440A (en) * | 2018-11-19 | 2019-03-29 | 深圳市第二人民医院 | The extracting method of excretion body |
| CN110231207A (en) * | 2019-05-23 | 2019-09-13 | 上海交通大学 | A method of separation excretion body |
| CN110511902A (en) * | 2019-05-09 | 2019-11-29 | 北京恩泽康泰生物科技有限公司 | Based on the separation of the extracellular vesica of exclusion chromatography and hyperfiltration technique and enrichment method |
| CN114397388A (en) * | 2022-01-11 | 2022-04-26 | 杭州昱鼎生物科技有限公司 | Urine exosome extraction kit based on combination of PEG precipitation method and SEC column method and application |
| CN114574437A (en) * | 2022-01-19 | 2022-06-03 | 大连博格林生物科技有限公司 | Plasma exosome extraction reagent, enrichment method, extraction kit and application thereof |
-
2022
- 2022-07-29 CN CN202210914640.8A patent/CN115354024A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2608509C1 (en) * | 2016-02-11 | 2017-01-18 | Елена Сергеевна Кастарнова | Method of obtaining blood exosomes |
| CN109536440A (en) * | 2018-11-19 | 2019-03-29 | 深圳市第二人民医院 | The extracting method of excretion body |
| CN110511902A (en) * | 2019-05-09 | 2019-11-29 | 北京恩泽康泰生物科技有限公司 | Based on the separation of the extracellular vesica of exclusion chromatography and hyperfiltration technique and enrichment method |
| CN110231207A (en) * | 2019-05-23 | 2019-09-13 | 上海交通大学 | A method of separation excretion body |
| CN114397388A (en) * | 2022-01-11 | 2022-04-26 | 杭州昱鼎生物科技有限公司 | Urine exosome extraction kit based on combination of PEG precipitation method and SEC column method and application |
| CN114574437A (en) * | 2022-01-19 | 2022-06-03 | 大连博格林生物科技有限公司 | Plasma exosome extraction reagent, enrichment method, extraction kit and application thereof |
Non-Patent Citations (2)
| Title |
|---|
| 韩杰 等: ""外泌体提取及保存技术研究进展"", 《中国细胞生物学学报》, vol. 43, no. 2, 28 February 2021 (2021-02-28), pages 451 - 459 * |
| 黄德发 等: ""三种方法提取血清外泌体的比较研究"", 《现代检验医学杂志》, vol. 36, no. 6, 30 November 2021 (2021-11-30), pages 139 - 142 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110540961B (en) | Annexin V-FITC exosome capture affinity magnetic bead, preparation method thereof and method for extracting exosome by using same | |
| CN110231207B (en) | Method for separating exosome | |
| CN113388520B (en) | Purification method of extracellular vesicles | |
| CN111321108A (en) | High-purity exosome density gradient centrifugation method | |
| JP2020530780A (en) | Isolation method of extracellular endoplasmic reticulum using hydrophobic interaction | |
| WO2024140378A1 (en) | Scale extraction method for exosomes in fresh milk | |
| CN113101737A (en) | Affinity tangential flow filtration system and construction method thereof, and exosome extraction method and application | |
| CN116083364A (en) | Method for obtaining exosomes with different sizes based on ultrafiltration device | |
| CN110411816B (en) | A method for enrichment of exosomes | |
| CN111996190A (en) | Whole blood genome DNA extraction kit | |
| CN114397388B (en) | Urine exosome extraction kit based on combination of PEG precipitation method and SEC column method and application | |
| CN106929467B (en) | A method and kit for isolating high-purity urinary exosomes | |
| CN110551687A (en) | A method for separating exosomes from plasma based on solid-phase metal affinity chromatography | |
| CN112322584A (en) | A simple method for exosome extraction | |
| CN118685347A (en) | A method for extracting and separating high-purity exosomes | |
| Kang et al. | Extracellular vesicle isolation methods | |
| CN215162612U (en) | Exosome extraction element | |
| CN115200969A (en) | Method and kit for efficiently separating and purifying plasma exosomes | |
| CN211347643U (en) | Device for purifying urine protein | |
| CN111172153B (en) | Method for extracting human urine exosome nucleic acid | |
| CN113754758A (en) | Method for purifying lipoprotein a | |
| CN111394307A (en) | A kind of method and application of separating and purifying exosomes from plasma | |
| CN116891848A (en) | A DNA extraction method from sheep blood samples | |
| CN118440893A (en) | Preparation method of high-purity stem cell exosome | |
| WO2023227082A1 (en) | Pathogen enrichment and detection method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221118 |
|
| RJ01 | Rejection of invention patent application after publication |